Is Psilocybin Safe?

Modern Research emphasized that the main risks of psilocybin are psychological and contextual rather than toxicological, meaning that set, setting, screening, and support are the most important safety factors.

Neuroscientist David Nutt, who leads psychedelic research at Imperial College London, is widely known for arguing that psilocybin has one of the safest pharmacological profiles among psychoactive drugs when used responsibly and in controlled settings.

Overall Conclusion From Large Modern Trials: Across hundreds of participants and multiple countries, research shows that psilocybin therapy appears medically safe and psychologically manageable when delivered in structured clinical settings with trained support.

1. Large Phase II Trials Found No Serious Drug-Related Medical Complications

2. Side Effects Were Mostly Short-Term and Predictable

3. Psychological Support Dramatically Improves Safety